SCHEMBL11620573

SCHEMBL11620573

CCCOC(=O)C=Cc1ccc(OCC(O)COc2ccc(Cl)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
MAOB P27338 1/20 0.51
APP P05067 2/20 0.50
LMNA P02545 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
PPARA Q07869 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
KDM4E B2RXH2 1/20 0.46
PTGS2 P35354 1/20 0.45
EGFR P00533 1/20 0.44
ERBB2 P04626 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propyl 3-(4-Chlorophenyl)Acrylate SCHEMBL19244385 0.86 APP (0.64) CYP1A2APPLMNATDP1MEN1
Propyl 3-(4-Chlorophenyl)Acrylate SCHEMBL19244387 0.86 APP (0.64) CYP1A2APPLMNATDP1MEN1
SCHEMBL11547633 0.85 PTGS2 (0.56) CYP1A2MAOBLMNAPPARAMEN1
SCHEMBL11621432 0.83 CYP1A2 (0.52) CYP1A2MAOBAPPLMNAMEN1
SCHEMBL19244225 0.82 APP (0.62) APPLMNATDP1MEN1KMT2A
SCHEMBL11546773 0.81 CYP1A2 (0.57) CYP1A2MAOBPPARAMEN1KMT2A
SCHEMBL19244431 0.81 APP (0.61) MAOBAPPLMNATDP1KMT2A
SCHEMBL19244350 0.81 APP (0.62) APPLMNATDP1ABCG2
SCHEMBL19244333 0.81 APP (0.66) MAOBAPPLMNATDP1MEN1
SCHEMBL19244334 0.81 APP (0.66) MAOBAPPLMNATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4073935-A Substituted propanol-(2)-derivatives and their nicotinic acid esters, and process for their preparation, and the use thereof as hypolipemic drugs KLINGE PHARMA GMBH & CO. (DT) 1978-02-14 US claimed